Antihypertensive effects of SGLT2 inhibitors in type 2 diabetes

Lancet Diabetes Endocrinol. 2016 Mar;4(3):188-189. doi: 10.1016/S2213-8587(15)00457-X. Epub 2015 Nov 25.
No abstract available

Publication types

  • Comment

MeSH terms

  • Antihypertensive Agents*
  • Diabetes Mellitus, Type 2 / drug therapy*
  • Humans
  • Hypoglycemic Agents / therapeutic use
  • Sodium-Glucose Transporter 2

Substances

  • Antihypertensive Agents
  • Hypoglycemic Agents
  • Sodium-Glucose Transporter 2